ArticleTechnology in cancer research & treatment

Sequential Administrations of a Vascular-Disrupting Agent, High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies.

Yue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.